News
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...
(Reuters) -The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily ...
Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...
4don MSN
Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every ...
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...
6d
Zacks.com on MSNPfizer's Strong Late-Stage Pipeline Can Drive Long-Term GrowthPFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.
European Commission President Ursula von der Leyen faces a rare no-confidence vote in the European Parliament this week.
The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
House Judiciary Chair Jim Jordan subpoenaed Dr. Philip Dormitzer after he refused to testify in the 2020 vaccine delay probe, ...
Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...
After several PD-1xVEGF competitors forged alliances with Big Pharma players, Summit Therapeutics, the frontrunner in this hot cancer drug field, is reportedly seeking its own deal. | After several PD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results